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Abstract
A total of 55 consecutive patients who experienced perioperative myocardial infarction (MI) after coronary artery bypass grafting were
studied using multislice computed tomography (MSCT) angiography to evaluate for graft patency. The MSCT detected acute graft occlusion
in 23% grafts. Of the 55 patients, 40% patients had occluded grafts and perioperative MI in the area of the grafted vessels; remaining 60%
had patent grafts with infarction in the area of the grafted vessels. Compared with the patients with patent grafts, those with occluded
grafts had a higher blood sugar level. In addition, graft occlusion was higher in grafts with severe distal disease. Among the patients with
patent grafts, luminal stenosis of the native vessels supplying the infarcted myocardium was higher than that in the native vessels supplying
the non-infarcted myocardium. In conclusion, MSCT is feasible for the assessment of graft patency in the setting of perioperative MI. Graft
occlusion is detected in less than half of the cases and usually occurs in the grafts with severe distal involvement and the patients with
uncontrolled hyperglycemia. In patients with patent grafts, the severity of luminal stenosis of the native grafted vessel is the main
predisposing factor for perioperative MI.
 2011 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
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1. Introduction
Coronary artery bypass grafting (CABG) is the main revas-
cularization modality in the treatment of the patients with
multivessel coronary artery disease (CAD). However, CABG
may be complicated by the perioperative myocardial infarc-
tion (MI). Perioperative MI, as defined by new Q waves on
the postoperative electrocardiogram (ECG), occurs in 4–5%
of patients, with a range among hospitals of 0–10% w1, 2x.
Acute ischemic injury of the myocardium is primarily caused
by the limitations of myocardial protection during the
procedure.
MI following CABG was associated with a significant in-
crease in intensive care unit time, hospital length of stay,
and overall costs, which contributed to greater hospital
and physician service costs w3x. Predictive risk factors and
the incidence of graft closure in this setting have not been
clearly established. The aim of the present study, there-
fore, is to determine the incidence and the predictors of
graft closure in the setting of perioperative MI following
CABG using multislice computed tomography (MSCT).
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2. Materials and methods
2.1. Study population
Between March 2008 and June 2010, 55 consecutive
patients who experienced perioperative MI within the first
week after CABG were included in this study. The enrolled
patients underwent 16-slice computed tomography (CT)
angiography to evaluate for graft patency. The study pro-
tocol was approved by the institution’s Ethics Committee
and written informed consent was obtained from all pati-
ents. Exclusion criteria were: serum creatinine )1.5 mg/dl
()133 mmolyl), allergy to contrast material, hyperthyroi-
dism, and inability to give informed consent.
2.2. Multidetector computed tomography angiography
protocol
Patients were scanned using a 16-section multidetector
CT scanner (SOMATOM Sensation 16, Siemens, Forchheim,
Germany). Patients were positioned in the gantry supine
position and feet first, with electrocardiographic leads
placed on the anterior thorax to enable a retrospectively
gated scan. Scan parameters were 140 kV, 0.4-s rotation
speed, 400 mA, and 10=0.75 detectors. Pitch, which was
dependent on the heart rate, averaged 0.3. The CT system
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automatically recommended a pitch value to optimize the
temporal resolution by the number of sectors reconstructed
from each scan. Scans were performed in the caudal to
cephalic direction, with a scan range from the thoracic
inlet through the lung bases. The proximal subclavian
arteries were also included. To familiarize the patient with
the protocol, the examination, including breath-holding,
was practiced in advance. b-Blockers (propranolol or esmo-
lol) were injected intravenously for heart rates exceeding
70 beats/min, unless underlying contraindications, such as
asthma were present. A non-ionic, iodinated, low-osmolar
contrast medium was injected intravenously in doses rang-
ing from 120 to 150 ml, without direct variation with
respect to patient weight. In addition, 20 ml saline flush
(saline chaser) was used to optimize the graft visualization.
2.3. Definitions
The perioperative MI is diagnosed based on the diagnostic
criteria of creatinine kinase isoenzyme MB (CK-MB or CK)
at least five times the upper limits of normal at -24 hours
postoperatively and if )24 hours, one of the following:
evolutionary ST segment elevation; new Q-waves in two or
more contiguous leads or new left bundle branch block; or
CK-MB (or CK) at least three times the upper limits of
normal w4x.
2.4. Data analysis
Variables are expressed as mean"standard deviation
(S.D.) for the continuous variables and as absolute or
relative frequencies for categorical variables. x -test was2
used for categorical data and Fisher’s exact test for cell
count -5. Patient characteristics were compared by means
of Student’s t-test in case of continuous variables. Other-
wise, a non-parametric test of Mann–Whitney U-test was
used. A stepwise logistic regression analysis was used to
determine the independent predictive factors for early
graft patency. A two-tailed P-0.05 was considered statis-
tically significant. The software SPSS version 15.0 (SPSS
Inc, Chicago, IL, USA) was used for statistical analysis.
3. Results
The study population comprised of 55 consecutive patients
with perioperative MI who completed the MSCT protocol.
There were 40 males and 15 females with a mean age of
60"9 years. The majority of the patients (ns47) had
three-vessel involvement in preoperative coronary angiog-
raphy. A total of the 177 grafts, consisting of 111 venous
grafts and 66 arterial grafts were evaluated, all of which
could be assessed for patency and occlusion using MSCT.
The MSCT detected acute graft occlusion in 41 (23%) grafts.
Of the 55 patients, 22 (40%) patients had occluded grafts
and perioperative MI in the territory of the grafted vessels;
the remaining 33 (60%) had patent grafts with infarction in
the territory of the grafted vessels. All patients had ele-
vated cardiac biomarker (CK-MB and troponin-I) levels.
3.1. Patency of arterial grafts
Of the 66 arterial grafts, 60 (90%) grafts were anasto-
mosed to the left anterior descending artery (LAD). The
arterial grafts to LAD consisted of 52 left internal mammary
artery (LIMA) grafts and eight radial artery (RA) graft. The
remaining arterial grafts included four right internal mam-
mary arteries (RIMA) to the right coronary artery (RCA) and
two RAs to the left circumflex artery (LCX) grafts. Based
on the MSCT, seven (11%) of the arterial grafts were
classified as occluded and 59 (89%) were patent. Six of the
52 LIMA grafts to LAD and one of the four RIMA grafts to
the RCA were found to be occluded.
3.2. Patency of venous grafts
Of the 111 venous grafts, 28 were anastomosed to the
LAD (and diagonal branches), 48 to the LCX (and obtuse
marginal branches), and 35 to the RCA (and posterior
descending artery). Acute graft occlusion was detected in
34 (31%) venous grafts, including 10 grafts (36%) in the LAD
territory, 15 grafts (31%) in the LCX territory, and nine
grafts (26%) in the RCA territory.
3.3. Electrocardiographic characteristics
Of the 55 patients, evolutionary ST-segment elevation was
observed in 17 (31%) patients in precordial leads V1–V6.
Eight patients (14.5%) showed evolutionary ST-segment
elevation in the inferior limb leads (II, III, aVF). New Q-
waves in at least two inferior limb leads were detected in
the four (7%) patients. In six (11%) patients, new Q-waves
were observed in at least two adjacent precordial leads.
No patients showed new left bundle branch block.
3.4. Risk factors of graft closure
The baseline clinical and demographical characteristics
were similar between the patients with patent and occlud-
ed coronary grafts (Table 1). The only differences observed
were related to the baseline fasting blood sugar (FBS) and
quality of the target artery. Compared with the patients
with patent grafts, those with occluded grafts had higher
blood sugar level w135"67 vs. 117"23 mg/dl (7.5"3.7 vs.
6.5"1.3 mmolyl), Ps0.03x. In addition, graft occlusion was
higher in grafts with severe distal disease (100% vs. 48%,
Ps0.003).
3.5. Risk factors of perioperative MI in patients with
patent grafts
Among the patients with patent grafts, luminal stenosis
of the native vessels supplying the infarcted myocardium
was higher than that in the native vessels supplying the
non-infarcted myocardium (85"10% vs. 57"9%, Ps0.001).
4. Discussion
The major findings of the present study are as follows:
(1) most of the perioperative MIs occurring after CABG are
not caused by the graft occlusion; (2) the severity of the
luminal stenosis in the bypassed native vessels is the main
factor responsible for the perioperative MI in the patients
with patent grafts; (3) the severe distal disease and the
hyperglycemia are the major predisposing factors for graft
occlusion after CABG.
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Table 1. Characteristics of the patients with patent and occluded grafts
Variable Patent graft (ns33) Occluded graft (ns22) P-value
Age (mean"S.D.) 60"9 60"8.5 0.98
Male gender (%) 79 68 0.38
Smoker (%) 54 55 0.96
Left main artery disease (%) 17 19 0.79
Mean LVEF before surgery (%) 44 46 0.32
Graft no. (mean"S.D.) 3.1"0.7 3.3"0.7 0.36
CPB time (mean"S.D., min) 121"52 120"53 0.76
Fasting blood sugar wmean"S.D., mg/dl (mmol/l)x 117"23 (6.5"1.3) 135"67 (7.5"3.7) 0.03
Severe distal disease in target vessel (%) 48 100 0.003
Aspirin 325 mg immediately after surgery (%) 92 87 0.60
LIMA graft (%) 96 94 0.70
LVEF, left ventricular ejection fraction; CPB, cardiopulmonary bypass; LIMA, left internal mammary artery.
The present study demonstrates that MSCT consistently
provides high-quality angiograms of bypass grafts that accu-
rately delineate the presence of graft occlusions or sten-
oses. Five studies have thus far reported on the accuracy
of MSCT to detect graft occlusionsystenoses. The foregoing
studies, having evaluated 225 patients via MSCT, compared
the results with those of conventional angiography and
reported a sensitivity of 85.7–100% and specificity of 94–
100% for MSCT w5–10x. A higher sensitivity (100%) and
specificity (98–100%) was reported for bypass graft
occlusion.
The present study also confirms the previous publications
on graft patency rate in perioperative MIs associated with
CABG. McKay et al. w8x found a 70% patency rate in 10
patients with perioperative MI using MSCT. In 18 patients
with perioperative MI soon after CABG, Brindis et al. w11x
reported a 78% graft patency rate. The present study with
larger patient population similarly showed that 60% of the
patients with perioperative MI had patent coronary grafts
in the territory of the infarcted myocardium. Even, late
(one year) angiographic study showed graft failure in 62%
of patients with perioperative MI w12x. Taken together, these
data indicated that and mechanisms other than graft failure
accounted for a substantial proportion of perioperative MIs
following CABG.
The present study also demonstrated that the severity of
the coronary obstruction in the grafted native vessel was
the main determinant of perioperative MI in the patients
with patent grafts. Similar results have been reported by
Brindis et al. and Yau et al. w11, 12x. These findings suggest
that acute ischemic injury of the myocardium is primarily
caused by inadequate myocardial protection during the
procedure. Because coronary blood flow is absent during
aortic cross-clamping for surgery utilizing CABG, protection
against the perioperative MI depends directly on the ability
to reduce myocardial oxygen requirements to a negligible
level.
Although the graft occlusion is responsible for the peri-
operative MI in a small group of the patients, this compli-
cation is more common in the grafts with severe distal
disease and the patents with uncontrolled hyperglycemia.
The association of hyperglycemia with early graft occlusion
may be related to a hypercoagulable state observed in
poorly controlled hyperglycemia. Boden et al. w13x demon-
strated that acute normalization of hyperglycemia with
insulin resulted in significant reduction of the tissue factor
procoagulant activity. Oysel et al. w14x provided important
evidences that support the hypothesis that coagulation
influences perioperative ischemia. In latter study, the
patients with perioperative MI had a lower serum levels of
protein C (101.2"26% vs. 124.7"31.4%, P-0.05) and tissue
plasminogen activator (322"580 vs. 2307"2830 IU/ml,
P-0.01). In our previous study, the patients with patent
coronary grafts had lower serum FBS level (6.6"1.6 vs.
7.8"3.6 mmolyl, Ps0.02) and longer partial thromboplas-
tin time (PTT) (34"11 vs. 30"2 s, Ps0.04) w15x. These
findings again highlighted the importance of technical
factors, good myocardial protection, and good metabolic
preparation in reducing the incidence of perioperative
MI occurring early after CABG.
5. Conclusions
MSCT is feasible for the assessment of graft patency in
the setting of perioperative MI associated with CABG. The
causes of perioperative MI in CABG patients are almost
certainly multifactorial, although not well understood.
Graft occlusion is detected in less than half of the cases
and usually occurs in the grafts with severe distal involve-
ment and the patients with uncontrolled hyperglycemia. In
patients with patent grafts, the severity of the luminal
stenosis of the native grafted vessel is the main predispos-
ing factor.
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This well-designed study w1x concerning perioperative myocardial infarction
(MI) and graft patency, offers us the opportunity to add some data regarding
this challenging complication. Coronary artery bypass grafting (CABG) is of
considerable benefit for those in need of revascularization; however, it may
be associated with significant perioperative and postoperative myocardial
damage and necrosis, which may occur in varying degrees. Multiple mecha-
nisms have been proposed to explain myocardial injury after CABG. Intra-
operative injury may result from cardiac manipulation, inadequate myo-
cardial protection, and intraoperative defibrillation, while postoperative
myocardial injury may be associated with acute loss of bypass grafts w2x.
The incidence of perioperative MI varies considerably, from 3% to 30%,
because of different diagnostic criteria and variable patient populations w3x.
However, troponin values more than five times the 99th percentile of the
normal reference range during the first 72 hours following CABG, when
associated with the appearance of new pathological Q-waves or new left
bundle-branch block (LBBB), or angiographically documented new graft or
native coronary artery occlusion, or imaging evidence of new loss of viable
myocardium, should be considered as diagnostic of a CABG related MI w4x.
The PREVENT IV study identified such intraoperative risk factors for
perioperative MI as prolonged cardiopulmonary bypass or aortic cross-clamp
times, perioperative myocardial ischemia, and inadequate revascularization.
Moreover, patients with perioperative MI also had longer surgery durations,
although it was unclear whether this longer duration was a cause of or
caused by perioperative myocardial ischemia. Other well-established risk
factors for perioperative MI included age, left main coronary artery disease
and three-vessel disease, impaired left ventricular function, unstable angina,
recent MI, and emergent operations w3x. According to the PREVENT IV study,
both 30-day and two-year clinical outcomes were worse in patients suffering
perioperative MI, as they had longer postsurgery ventilation times and
intensive care unit and hospital stays. Although rates of angiographic vein
graft failure were higher in patients with a perioperative MI, one-third of
patients with perioperative MI had patent vein grafts at one-year, which
suggests that a substantial portion of perioperative MI was not caused by
early vein graft failure and that global or regional myocardial ischemia,
possibly related to CABG or worse coronary anatomy, may have an important
role w3x.
Finally, reperfusion injury occurring with restoration of blood flow to
ischemic tissue is associated with myocardial cell death and apoptosis, and
microvascular injury. Three to 20% of patients experience MI associated with
reperfusion injury after CABG w5x. Adenosine, being a powerful inducer of
ischemic preconditioning, has been shown to improve postischemic ventric-
ular function, reduce neutrophil accumulation/activation and reduce further
myocardial necrosis. Mangano et al. w5x, reported that treatment with
acadesine, an adenosine regulating agent, significantly reduced mortality by
4.3-fold, with the principal benefit occurring over the first 30 days after MI.
Acadesine is the first therapy proven to reduce the severity of acute
postreperfusion MI, substantially reducing the risk of dying over the two
years after infarction.
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